Skip to content

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
  • Home
  • About
    • NIH Collaboratory
      • Coordinating Center
      • NIH Collaboratory Trials
      • Core Working Groups
      • Steering Committee
      • Distributed Research Network
      • Our Impact
    • Living Textbook
      • Table of Contents
      • How to Use This Site
  • Resources
    • Data and Resource Sharing
    • Training Resources
    • Tools for Researchers
    • Publications
    • Knowledge Repository
  • Webinar
  • Podcast
  • News
    • News Feed
    • Calendar
    • Subscribe
return to home
Subscribe to Newsletter go to twitter feed go to linkedin go to blue sky feed
Search
NIH Collaboratory
Living Textbook of
Pragmatic Clinical Trials

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
home button

Rethinking Clinical Trials

A Living Textbook of Pragmatic Clinical Trials

  • Design
    • What is a Pragmatic Clinical Trial?
    • Decentralized Pragmatic Clinical Trials
    • Developing a Compelling Grant Application
    • Experimental Designs and Randomization Schemes
    • Endpoints and Outcomes
    • Analysis Plan
    • Using Electronic Health Record Data
    • Building Partnerships and Teams to Ensure a Successful Trial
    • Intervention Delivery and Complexity
    • Patient Engagement
  • Data, Tools & Conduct
    • Assessing Feasibility
    • Acquiring Real-World Data
    • Assessing Fitness-for-Use of Real-World Data
    • Study Startup
    • Participant Recruitment
    • Monitoring Intervention Fidelity and Adaptations
    • Patient-Reported Outcomes
    • Clinical Decision Support
    • Mobile Health
    • Electronic Health Records–Based Phenotyping
    • Navigating the Unknown
  • Dissemination & Implementation
    • Data Sharing and Embedded Research
    • Dissemination Approaches for Different Audiences
    • Implementation
    • End-of-Trial Decision-Making
  • Ethics & Regulatory
    • Privacy Considerations
    • Identifying Those Engaged in Research
    • Collateral Findings
    • Consent, Disclosure, and Non-Disclosure
    • Data and Safety Monitoring
    • Ethical Considerations of Data Sharing in Pragmatic Clinical Trials
    • Ethics for AI and ML
    • IRB Responsibilities and Procedures

Specific Uses for EHR Data in PCTs

CHAPTER SECTIONS

Using Electronic Health Record Data in Pragmatic Clinical Trials


Section 5

Specific Uses for EHR Data in PCTs

Expand Contributors
Rachel Richesson, MS, PhD, MPH
Richard Platt, MD, MSc
Gregory Simon, MD, MPH
Lesley Curtis, PhD
Reesa Laws, BS
Adrian Hernandez, MD, MSH
Jon Puro, MPA-HA
Doug Zatzick, MD
Erik van Eaton, MD, FACSKeith A Marsolo, PhD
Vincent Mor, PhD

Contributing Editor
Karen Staman, MS

EHR data and systems can be used to support 5 major activities of pragmatic trials, which include:

  • Preparation: Estimating the potential study population
    • Estimating numbers of eligible patients
    • Estimating rates of study outcomes among eligible patients
    • Estimating clustering (intraclass correlation) to inform sample size calculations
  • Enrollment or recruitment: Identifying the study population, often in terms of phenotypes or clinical profiles including current health status or medical history
    • Identifying a cohort of patients for screening, recruitment, or enrollment.
    • Identifying clusters (clinicians, clinics, etc.) for cluster-randomized or stepped-wedge trials
  • Assessing baseline prognostic characteristics of the research sample or cohort for a number of objective and subjective measures
    • In a cluster-randomized design, patient populations may be unbalanced due to facility differences in patient mix. Prognostic factors can be used to detect the balance (or imbalance) of specified independent variables. However, if the factors are used as part of the stratification scheme for cluster-randomization, then this type of balancing is not possible.
    • Example of an objective measure: definitive lab values for a specific disease, such as chronic kidney disease or HbA1C for diabetes control. (These are subject, of course, to the kinds of limitations noted above. In PCTs, investigators make do with whatever value is in the chart, typically without capturing any information about the clinical lab’s quality control values for these tests.)
    • Example of a subjective measure: clinical judgement about autism spectrum disorder or an observation by a clinician on skin discoloration or patient discomfort.
  • Implementing and monitoring the delivery of an intervention (using EHR system functions, such as alerts and computerized provider order entry (CPOE) interfaces)
  • Measuring the outcomes for both the intervention and control populations.
    • Longitudinal data linkage—following a cohort of patients over time may require aggregating data from multiple encounters, providers, and information systems. Linkage techniques to ensure that the correct data are being applied to each patient are critical for randomized PCTs, especially if the longitudinal data are being used to measure the effectiveness of the intervention.

In the following sections, we describe each of these uses for EHR data by PCT activity.

Previous Section Next Section

SECTIONS

CHAPTER SECTIONS

sections

  1. Introduction
  2. Interoperability
  3. Data as a Surrogate for Clinical Phenomena
  4. Developing and Refining the Research Questions
  5. Specific Uses for EHR Data in PCTs
  6. Estimating and Identifying the Study Population and Assessing Baseline Prognostic Characteristics
  7. Implementing and Monitoring the Delivery of an Intervention
  8. Assessing Outcomes
  9. The Research Question Drives the Data Requirements
  10. Additional Resources

Resources

Utilization of EHRs for clinical trials: a systematic review

Systemic review to identify how EHRs can support and enhance clinical trials.

For more on data linkage, see the article Health Services Research and Data Linkages: Issues, Methods, and Directions for the Future

The National Center for Health Statistics provides this list of Data Linkage Resources


Version History

October 7, 2025: Updated text as part of annual review (changes made by K. Staman).

August 26, 2022: Updates made as part of annual review (changes made by K. Staman).

January 18, 2021: Added EHR Workshop video module to resource bar (changes made by K. Staman).

July 3, 2020: Minor corrections to layout and formatting (changes made by D. Seils).

November 30, 2018: Updated text as part of annual update (changes made by K. Staman).

Published August 25, 2017

current section :

Specific Uses for EHR Data in PCTs

  1. Introduction
  2. Interoperability
  3. Data as a Surrogate for Clinical Phenomena
  4. Developing and Refining the Research Questions
  5. Specific Uses for EHR Data in PCTs
  6. Estimating and Identifying the Study Population and Assessing Baseline Prognostic Characteristics
  7. Implementing and Monitoring the Delivery of an Intervention
  8. Assessing Outcomes
  9. The Research Question Drives the Data Requirements
  10. Additional Resources

Citation:

Richesson R, Platt R, Simon G, et al. Using Electronic Health Record Data in Pragmatic Clinical Trials: Specific Uses for EHR Data in PCTs. In: Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. Bethesda, MD: NIH Pragmatic Trials Collaboratory. Available at: https://rethinkingclinicaltrials.org/chapters/design/using-electronic-health-record-data-pragmatic-clinical-trials-top/specific-uses-ehr-data-pcts/. Updated October 7, 2025. DOI: 10.28929/033.

Footer Menu

  • How to Use This Site
  • About NIH Collaboratory
  • Enrollment Reporting
  • Grand Rounds
  • Funding Statement
Link to Twitter Link to LinkedIn Link to Blue Sky Link to NIH Collaboratory email

Reference in this Web site to any specific commercial products, process, service, manufacturer, or company does not constitute its endorsement or recommendation by the U.S. Government or National Institutes of Health (NIH). NIH is not responsible for the contents of any “off-site” Web page referenced from this server.

Log in
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly. Site Map